孟鲁斯特对哮喘模型IL-5mRNA和IL-5蛋白表达的影响被引量：2

Effects of Montelukast on Expression of IL -SmRNA and IL -5 Protein in Asthmatic Model

下载PDF

导出

摘要目的探讨白三烯受体拮抗剂孟鲁斯特(MK)对哮喘小鼠IL-5mRNA、IL-5蛋白表达的影响。方法采用原位杂交、免疫组化LSAB法,检测哮喘小鼠及孟鲁斯特治疗后哮喘小鼠骨髓细胞IL-5mRNA的表达及肺、骨髓、脾IL-5蛋白的表达情况。结果孟鲁斯特可显著减轻哮喘小鼠肺组织炎症细胞浸润、细支气管痉挛、粘液分泌等;亦可减少骨髓IL-5mRNA阳性细胞数(P<0.02),并使骨髓、肺、脾IL-5蛋白表达下降。结论白三烯受体拮抗剂孟鲁斯特不仅使肺部炎症显著减轻,也抑制骨髓细胞表达IL-5mRNA、IL-5蛋白,提示白三烯可能通过调节炎症细胞、细胞因子合成来应答过敏原反应。 Objective To investigate the effect of the leukotriene receptor antagonist Montelukast ( MK) on the expressions of IL -SmRNA and IL -5 protein in ovalbumin-sensitized Balb/c mice. Methods Immunocytochemistry and in situ hybridization were used to examine the expressions of IL - 5 protein and IL -SmRNA in the tissue cells of the bone marrow, lung and spleen respectively. Results Animals treated with MK had significantly less inflammatory cells and secretion of mucus compared with OVA - sensitized Balb/c mice. MK could decrease IL -SmRNA cells in bone marrow ( P < 0.02) , and inhibited the expression of IL - 5 protein in the bone marrow, lung and spleen. Conclusion Leukotriene receptor antagonist MK not only attenuated pulmonary inflammation of lung but also inhibited the expressions of IL - SmRNA and IL - 5 protein in bone marrow cells, suggesting that leukotriene may also regulate the allergic response through mudulation of inflammation and cytokine synthesis.

作者白建文邓伟吾

机构地区上海第二医科大学瑞金医院肺科

出处《上海第二医科大学学报》 CSCD 2003年第3期216-219,共4页 Acta Universitatis Medicinalis Secondae Shanghai

关键词白三烯受体拮抗剂孟鲁斯特哮喘动物模型白细胞介素-5 炎症细胞因子过敏原反应 Montelukast asthmatic mouse IL - 5

分类号 R562.25 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献12

1Henderson BW, Lewis DB, Alber RK, et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma[J]. J Exp Med, 1996,184(10): 1483-1494.
2Minshall EM, Schleimer R, Cameron L, et al. Interleukin 5 expression in the bone marrow of sensitized Balb/c mice after allergen challenge[J]. Am J Respir Cirt Care Med, 1998, 158:951-957.
3Figueroa DJ, Breyer RM, Defoe SK, et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes[J]. Am J Respir Crit Care Med, 2001, 163: 226-233.
4Paul S, Foster AW, Yang MM, et al. Elemental signals regulating eosinophil accumulation in the lung[J]. Immunological Reviews, 2001, 179: 173-181.
5Therattil J, Wang YC, Than S, et al. In vitro effects of montelukast on levels of IL-5 mRNA and cysteinyl leukotriene (cysLT) in allergen-stimulated peripheral blood mononuclear cells (PBMC) from patients with asthma (abstract)[J]. Ann Allergy Asthma Immunol, 1999, 82:80.
6Inaku D, Cameron L, Suzuki M, et al. Montelukast, a leukotriene receptor antagonist, inhibits the late airway respone to antigen, airway eosinophilia, and IL-5-expressing cells in Brown Norway rats[J]. J Allergy Clin Immunol, 1999, 104(6) 1147-1154.
7Cowburn AS, Holgate ST, Sampson AP, et al. IL-5 increase expression of 5-lipoxygenase activating protein and translocate 5-lipoxygenase to the nucleus in human blood eosinophils[J]. J Immunology, 1999, 163: 456-465.
8Thivierge M, Doty M, Johnson J, et al. IL-5 up regulates cysteinyl leukotriene 1 receptor expression in HL 60cells differentiated into eosinophils[J]. J Immunology, 2000, 165: 5221-5226.
9Gaspar EM, Joseph D, Elasa PX, et al. Rapid increase in bone marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge[J]. Am J Respir Cell Mol Biol, 1997, 17: 404-413.
10Tomaki M, Lin Ling Z, Lundahl J, et al. Eosinophilopoiesis in a murine model of allergic airway eosinophilia: involvement of bone marrow IL-5 and IL-5 receptor α1[J]. J Immunology, 2000, 165: 4040-4050.